Detalles de la búsqueda
1.
Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
BJU Int;
123(3): 519-529, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30216622
2.
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
BJU Int;
118(5): 804-813, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27124889
3.
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
J Sex Med;
11(3): 840-56, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24308723
4.
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
J Sex Med;
10(6): 1612-27, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23551886
5.
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function.
World J Mens Health;
38(1): 68-77, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209900
Resultados
1 -
5
de 5
1
Próxima >
>>